Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Payables (2016 - 2025)

Nu-Med Plus' Payables history spans 10 years, with the latest figure at $27744.0 for Q4 2021.

  • On a quarterly basis, Payables rose 6.51% to $27744.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $27744.0, a 6.51% increase, with the full-year FY2021 number at $27744.0, up 6.51% from a year prior.
  • Payables hit $27744.0 in Q4 2021 for Nu-Med Plus, up from $18544.0 in the prior quarter.
  • Over the last five years, Payables for NUMD hit a ceiling of $313910.0 in Q1 2017 and a floor of $12645.0 in Q1 2021.
  • Historically, Payables has averaged $198340.5 across 5 years, with a median of $236622.0 in 2018.
  • Biggest five-year swings in Payables: grew 26.58% in 2017 and later crashed 94.86% in 2021.
  • Tracing NUMD's Payables over 5 years: stood at $234100.0 in 2017, then rose by 2.47% to $239882.0 in 2018, then increased by 12.52% to $269920.0 in 2019, then crashed by 90.35% to $26048.0 in 2020, then grew by 6.51% to $27744.0 in 2021.
  • Business Quant data shows Payables for NUMD at $27744.0 in Q4 2021, $18544.0 in Q3 2021, and $26000.0 in Q2 2021.